Steve Miller - 05 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Op. & Scientific Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
05 Dec 2023
Net transactions value
-$569,600
Form type
4
Filing time
07 Dec 2023, 17:00:14 UTC
Previous filing
12 May 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Sale $569,600 -40,000 -5.8% $14.24 647,457 05 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to fund the exercise price and tax withholding associated with the exercise of a stock option that will expire on January 3, 2024 and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in a range from $14.23 to $14.26 per share.